This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "retinoid_visual_cycle_disruption#Chromophore Insufficiency and Retinoid Intermediate Accumulation"). Gene substitutions a conforming trigger node makes: RPE65 (all-trans-retinyl ester isomerohydrolase) and LRAT (retinol esterification) in Leber congenital amaurosis and early-onset severe retinal dystrophy; RDH5 (11-cis-retinol dehydrogenase) in fundus albipunctatus; RLBP1 (CRALBP) in retinitis punctata albescens and Bothnia dystrophy; ABCA4 (outer-segment flippase clearing N-retinylidene-PE) in Stargardt disease and ABCA4 retinopathy; RDH12 in early-onset severe retinal dystrophy; and STRA6 / RBP4 where the lesion is upstream retinol delivery to the RPE rather than the cycle itself.
Which arm a conformer enters through matters and should be stated explicitly, because the two arms take OPPOSITE therapeutic directions. A chromophore-supply lesion is treated by restoring flux - RPE65 gene replacement, or artificial 9-cis-retinoid chromophore. A clearance lesion is treated by SLOWING flux - visual-cycle modulators and deuterated vitamin A reduce the substrate available to form bisretinoid. Wiring a Stargardt entry to an RPE65-style restorative treatment pattern, or vice versa, inverts the mechanism. The module's treatments block therefore carries both, each pinned to its own arm, and neither is inherited by conformers.
SCOPE. This module covers chromophore regeneration and retinoid clearance. The cGMP signalling cascade that consumes the chromophore is phototransduction_cascade_dysfunction; the photoreceptor death programme downstream of either arm is photoreceptor_degeneration. Disorders commonly conform to two of the three in parallel.
Why does an equivalent-looking block in the retinoid relay produce stationary night blindness at one step and severe congenital blindness at another, and is enzymatic redundancy sufficient to explain the difference?
KNOWLEDGE GAP
visual_cycle_arm_severity_determinants
Attached to:
Chromophore Insufficiency and Retinoid Intermediate Accumulation
Delayed Dark Adaptation and Night Blindness
Loss of RDH5 gives fundus albipunctatus, a mild stationary night blindness with preserved daytime vision, whereas loss of RPE65 gives Leber congenital amaurosis. Mouse work shows retinol dehydrogenases compensate for each other such that even triple knockouts still regenerate chromophore, which suggests redundancy explains the mild end. But it does not follow that redundancy explains the whole severity range, and the RDH8/RDH12 result shows the same enzymes are non-redundant for clearance while redundant for supply. Without resolving this, a conformer cannot predict from its lesion whether it should also wire to photoreceptor_degeneration.
Proposed experiments:
Quantitative retinoid flux measurement across a graded allelic series
Visual Cycle Enzyme or Transporter Defect
trigger
The initiating lesion is a variant in a gene encoding a component of the retinoid cycle. The affected protein may sit on the regeneration relay - LRAT esterifying all-trans-retinol, RPE65 isomerohydrolysing the ester to 11-cis-retinol, RDH5 oxidising it to 11-cis-retinal, CRALBP chaperoning cis-retinoids between those steps - or on the clearance side, where ABCA4 flips N-retinylidene-phosphatidylethanolamine out of the disc lumen and the retinol dehydrogenases reduce free all-trans-retinal. A lesion upstream of the eye entirely, in retinol delivery to the RPE, enters the same chain.
Downstream
-
Impaired Retinoid Flux Between Photoreceptor and Retinal Pigment Epithelium
Show evidence (2 references)
"Retina specific proteins carry out the majority of the visual cycle, and any significant interruption in this sequence of reactions is capable of causing varying degrees of blindness."
States the module's premise directly: the cycle is executed by a defined set of retina-specific proteins, and a lesion in any of them is sufficient to cause visual loss. Evidence source is OTHER because this is a review.
"Deleterious mutations in these genes are identified in human retinal diseases that cause blindness, such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP)."
Names LRAT and RPE65 specifically as the human disease genes behind the chromophore-supply arm of this trigger. Evidence source is OTHER because this is a review.
Impaired Retinoid Flux Between Photoreceptor and Retinal Pigment Epithelium
amplifier
The visual cycle is a two-compartment relay: bleached all-trans-retinal leaves the photoreceptor outer segment, is processed through the retinal pigment epithelium, and returns as 11-cis-retinal to recombine with opsin. A defective step stalls that traffic. Substrate backs up behind the block - retinyl esters in LRAT-competent RPE65 deficiency, cis-retinoids in RDH5 deficiency - and product falls short downstream. Because the relay crosses a cell boundary, the consequences are shared between two cell types that neither can escape: the photoreceptor is starved of chromophore while the RPE is left holding the intermediates.
Downstream
-
Chromophore Insufficiency and Retinoid Intermediate Accumulation
Show evidence (2 references)
"A series of enzymatic reactions, located in both the photoreceptor outer segment and the retinal pigment epithelium, transform retinol into the visual chromophore 11-cis-retinal, regenerating visual pigments."
Establishes the two-compartment relay whose interruption this node models, and locates the steps in the outer segment and the RPE as the description asserts. Evidence source is OTHER because this is a review.
"Lack of 11-cis-RDH leads to an accumulation of cis-retinoids, particularly 13-cis-isomers."
Demonstrates the substrate backup this node asserts: removing one relay enzyme causes the retinoids upstream of it to accumulate in the RPE.
RPE Lipofuscin Loading and Retinal Pigment Epithelium Dysfunction
effector
Bisretinoids formed from uncleared all-trans-retinal are transferred to the retinal pigment epithelium with each day's phagocytosed outer-segment discs. Being neither degradable nor exportable, they accumulate in RPE lysosomes as autofluorescent lipofuscin, whose photooxidation products damage the cell. A failing RPE then withdraws the phagocytic, metabolic and retinoid support that overlying photoreceptors cannot survive without, which is why a clearance-arm defect expressed in one cell type kills the other.
Downstream
-
Progressive Photoreceptor and Retinal Pigment Epithelium Degeneration
Show evidence (1 reference)
"Biallelic pathogenic variants in the ABCA4 gene cause impaired clearance of retinoid byproducts, leading to toxic bisretinoid accumulation, retinal pigment epithelium dysfunction, and progressive photoreceptor degeneration."
States this node's whole causal sequence for the archetypal clearance-arm disorder: failed retinoid clearance, bisretinoid accumulation, RPE dysfunction, and photoreceptor loss. Evidence source is OTHER because this is a review.
Delayed Dark Adaptation and Night Blindness
effector
The direct functional consequence of chromophore insufficiency, and the module's most sensitive early readout. Recovering sensitivity after a bleach requires resynthesised 11-cis-retinal, so a stalled cycle is measured as prolonged dark adaptation before any structural change is visible. Severity scales with where the block sits: a redundant step such as RDH5 gives a strikingly mild, essentially stationary night blindness with a normal daytime retina, whereas loss of the isomerohydrolase gives severe congenital visual impairment. Rods are affected first and most because their pigment demand is highest, but cone dark adaptation is delayed as well.
Show evidence (2 references)
"In humans, mutations in this gene are associated with fundus albipunctatus, a disease expressed by delayed dark adaptation of both cones and rods."
Ties a specific relay-enzyme lesion to delayed dark adaptation in humans, and supports the claim that both photoreceptor classes are affected rather than rods alone.
"fundus albipunctatus (FA), a rare form of congenital stationary night blindness that is characterized by the presence of white dots in the midperiphery of the retina and delayed dark adaptation"
Supports the mild, stationary end of the severity range this node asserts: a redundant-step visual-cycle lesion presenting as congenital stationary night blindness with delayed dark adaptation.
Progressive Photoreceptor and Retinal Pigment Epithelium Degeneration
consequence
The terminal consequence, reached from either arm. Chromophore starvation leaves opsin unliganded, which is itself destabilising, and bisretinoid loading poisons the supporting epithelium; both routes end in loss of photoreceptors and of the RPE beneath them, with the atrophy distributed according to the lesion - macular in ABCA4 retinopathy, widespread in RPE65-associated disease. This node marks the seam to photoreceptor_degeneration, which models the death programme itself; it is not re-derived here, and a degenerating conformer should declare conformance to both modules.
Show evidence (2 references)
"Three-month-old Rdh8(-/-)Rdh12(-/-) mice characteristically displayed a slowly progressing rod-cone dystrophy accompanied by accumulation of N-retinylidene-N-retinylethanolamine (A2E), a toxic substance known to contribute to retinal degeneration."
Shows the clearance arm reaching this terminal node in vivo, with the bisretinoid species named and progressive rod-cone dystrophy as the outcome.
"ABCA4-associated retinopathies (Stargardt disease) are the most common inherited macular dystrophy and a leading cause of early onset central vision loss."
Establishes the macular distribution and clinical weight of this endpoint for the archetypal clearance-arm disorder. Evidence source is OTHER because this is a review.
RPE65 Gene Replacement (Voretigene Neparvovec)
Platform:
Gene therapy
Subretinal AAV2 delivery of human RPE65 to the retinal pigment epithelium, restoring isomerohydrolase activity and with it 11-cis-retinal supply. This is the drug-target pattern for the CHROMOPHORE-SUPPLY arm only: it works by increasing retinoid flux through the cycle, which is exactly the wrong direction for a clearance-arm disorder. It is a mechanism pattern here, not a treatment recommendation, and conforming disorders do not inherit it.
Evidence: 1
Visual Cycle Modulation for the Retinoid Clearance Arm
Platform:
Small molecule
The mechanistic inverse of gene replacement. Where the lesion is failure to clear retinoid byproducts, the therapeutic aim is to REDUCE flux through the cycle so less all-trans-retinal is available to form bisretinoid - visual cycle modulators, deuterated vitamin A analogues, and retinol-binding-protein antagonists all act this way. Recorded here so the module carries both directions explicitly and a conformer cannot pick up the wrong one; it is a mechanism pattern, not a treatment recommendation, and no agent in this class is approved.
Evidence: 1